Alamar Biosciences Inc.
ALMR | NASDAQ
$28.89
-$1.71 (-5.59%)
Nov 2, 2026, 3:44 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Net Income | -34.52M | -21.33M |
Depreciation & Amortization | 2.3M | 1.17M |
Stock-Based Compensation | n/a | n/a |
Other Working Capital | -9.01M | -4.61M |
Other Non-Cash Items | 16.72M | 11.2M |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | -16.17M | -11.39M |
Operating Cash Flow | -31.67M | -20.35M |
Capital Expenditures | -4.24M | -600K |
Cash Acquisitions | n/a | n/a |
Purchase of Investments | -117.05M | n/a |
Sales Maturities Of Investments | n/a | n/a |
Other Investing Acitivies | n/a | n/a |
Investing Cash Flow | -121.57M | -778K |
Debt Repayment | 56.18M | 56.18M |
Common Stock Repurchased | n/a | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | n/a | n/a |
Financial Cash Flow | 257.6M | 55.76M |
Net Cash Flow | 132.97M | 64.59M |
Free Cash Flow | -35.91M | -20.95M |
Adj. Free Cash Flow | -35.91M | -20.95M |
Maintenance CapEx | n/a | n/a |
Growth CapEx | n/a | n/a |
Owner Earnings | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ALMR